文献速递临床试验与 GCP

术中伤口冲洗预防剖腹术后手术部位感染(IOWISI):随机对照试验研究方案

Intraoperative wound irrigation to prevent surgical site infection after laparotomy (IOWISI): study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2017-09-04

IOWISI试验为多中心、观察者与患者盲法、三组平行随机对照试验,比较剖腹内脏手术后关皮前用0.04%聚己缩胍(PHX)溶液冲洗与不冲洗(试验1)或生理盐水冲洗(试验2),主要终点为术后30天内手术部位感染率,样本量540例。

要点

  • 剖腹内脏手术后手术部位感染率高达14-25%,目前缺乏高级别证据支持术中伤口冲洗的明确推荐。
  • IOWISI试验三组平行:0.04% PHX溶液冲洗 vs 不冲洗(试验1) vs 生理盐水冲洗(试验2)。
  • 主要终点为术后30天内SSI率,按意向性治疗人群分析,样本量540例。

核心结论

  • IOWISI试验将为PHX或生理盐水术中伤口冲洗的临床应用提供高级别证据,并可能影响未来临床指南与实践。

研究设计与样本

  • 多中心、随机、观察者与患者盲法、三组平行对照临床试验,比较关皮前0.04% PHX溶液冲洗与不冲洗(试验1)或生理盐水冲洗(试验2)。
  • 纳入人群为接受剖腹内脏手术且污染级别II-IV级的患者,样本量n=540。
  • 主要终点为术后30天内手术部位感染率,按意向性治疗人群分析。
  • 试验注册于德国临床试验注册中心DRKS00012251,注册日期2017年7月3日。

关键数值与推荐

  • 主要终点统计检验全局显著性水平:试验1为2.5%,试验2为5%。
  • 样本量n=540,把握度试验1为94%,试验2为85%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Postoperative surgical site infection (SSI) is one of the most common hospital infections and contributes substantially to postoperative morbidity and mortality. In addition, SSIs dramatically increase the treatment cost and length of hospital stay. Following visceral surgery by laparotomy, SSI rates are especially high (14-25%). Therefore, measures to prevent SSI in this field are urgently needed. Prophylactic intraoperative wound irrigation (IOWI) of the subcutaneous soft tissue before skin closure hypothetically represents an easy and economical option to reduce SSI rates and is already frequently used in clinical practice. However, there are currently no definite recommendations on the use of IOWI since high-level evidence supporting its use is lacking. Consequently, clinical practice varies widely. Antiseptic polyhexanide (PHX)-based solutions are approved for soft-tissue wound irrigation in surgery but have not been specifically evaluated in randomized clinical trials for the prevention of SSI following laparotomy for visceral surgery. METHODS/DESIGN: The IOWISI trial is a multicentre, randomized, observer- and patient-blinded clinical trial with three parallel treatment groups, comparing IOWI with a 0.04% PHX solution to no irrigation (test 1) or saline (test 2) before skin closure after laparotomy for visceral surgery (contamination level II-IV). The primary endpoint of the trial is the SSI rate within 30 days postoperatively. Statistical analysis of the primary endpoint measure will be based on the intention-to-treat population. The global level of significance is set at 2.5% for test 1 and 5% for test 2 and the sample size (n = 540) is determined to assure a power of 94% (test 1) and 85% (test 2). DISCUSSION: The IOWISI trial will provide high-level evidence as a basis for clinical recommendations regarding the use of IOWI with PHX or saline and will potentially impact on future clinical guidelines and practice. The pragmatic trial design guarantees high external validity. TRIAL REGISTRATION: Registered at the German Clinical Trials Register, DRKS00012251 . Registered on 3 July 2017.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Mueller TC, Nitsche U, Kehl V, et al. Intraoperative wound irrigation to prevent surgical site infection after laparotomy (IOWISI): study protocol for a randomized controlled trial. Trials. 2017. PMID: 28870242. doi:10.1186/s13063-017-2154-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。